Tyler Bussian
Stock Analyst at Brookline Capital
(0.19)
# 4,121
Out of 4,761 analysts
5
Total ratings
25%
Success rate
-27.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $1.48 | +508.11% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $2.28 | +2,663.16% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $10 | $1.27 | +687.40% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $2.13 | +322.54% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $1.48
Upside: +508.11%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $2.28
Upside: +2,663.16%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $1.27
Upside: +687.40%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $2.13
Upside: +322.54%